Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Released Nov 7, 2024, after the close
10-Q filed Nov 7, 2024, 38 days after period end · 0001516551-24-000110
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$3.90M | -$24.95M | -$3.13M | -$1.82M |
| EPS Diluted | -$0.10 | -$3.17 | -$1.58 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
